## CYM #1 â€“ Intermediate risk (Group B)

**Cytarabine (CY)**
-	Route: IV infusion over 20 hours
-	Dosage: 100 mg/m2/dose, in 250ml NS, continuous infusion over 20 hours 
-	Used on Days 2 to 6 (total 5 doses)
-	Caution: in FAB LMB 96 protocol, Cytarabine is infused over 24h, totally continuously from Day 2 to Day 6

**High Dose Methotrexate (DM)**
-	Route: IV over 4 hours
-	Dosage: 3 g/m2/dose, diluted in 250ml NS, infusion over 4 hours 
-	Used on Day 1
-	Caution: IV folinic 15 mg/m2/dose every 6 hourly x 4 doses starting at 24 hrs after start of IV MTX and continue until MTX level is < 0.1 uM.

**Triple Intrathecal (TIT)** 
Triple intrathecal (IT) therapy doses, according to patient age, are as follows:
-	For patients under 1 year of age, administer methotrexate 8 mg, hydrocortisone 8 mg, and cytarabine 16 mg, in a total volume of 3 mL.
-	For patients aged 1 to 2 years, administer methotrexate 10 mg, hydrocortisone 10 mg, and cytarabine 20 mg, in a total volume of 4 mL.
-	For patients aged 2 to 3 years, administer methotrexate 12 mg, hydrocortisone 12 mg, and cytarabine 24 mg, in a total volume of 5 mL.
-	For patients older than 3 years, administer methotrexate 15 mg, hydrocortisone 15 mg, and cytarabine 30 mg, in a total volume of 6 mL.
-	These doses are to be given on Day 1 and Day 7
